These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


429 related items for PubMed ID: 18928350

  • 1. Cognitive changes in multiple sclerosis.
    Amato MP, Zipoli V, Portaccio E.
    Expert Rev Neurother; 2008 Oct; 8(10):1585-96. PubMed ID: 18928350
    [Abstract] [Full Text] [Related]

  • 2. [Cognitive impairment].
    Reuter F, Audoin B, Rico A, Malikova I, Ranjeva JP, Pelletier J.
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cognitive impairment in early stages of multiple sclerosis.
    Amato MP, Portaccio E, Goretti B, Zipoli V, Hakiki B, Giannini M, Pastò L, Razzolini L.
    Neurol Sci; 2010 Nov; 31(Suppl 2):S211-4. PubMed ID: 20640466
    [Abstract] [Full Text] [Related]

  • 10. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
    Dineen RA, Vilisaar J, Hlinka J, Bradshaw CM, Morgan PS, Constantinescu CS, Auer DP.
    Brain; 2009 Jan; 132(Pt 1):239-49. PubMed ID: 18953055
    [Abstract] [Full Text] [Related]

  • 11. Cognitive impairment and structural brain damage in benign multiple sclerosis.
    Rovaris M, Riccitelli G, Judica E, Possa F, Caputo D, Ghezzi A, Bertolotto A, Capra R, Falautano M, Mattioli F, Martinelli V, Comi G, Filippi M.
    Neurology; 2008 Nov 04; 71(19):1521-6. PubMed ID: 18815387
    [Abstract] [Full Text] [Related]

  • 12. Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis.
    Ranjeva JP, Audoin B, Au Duong MV, Confort-Gouny S, Malikova I, Viout P, Soulier E, Pelletier J, Cozzone PJ.
    J Neurol Sci; 2006 Jun 15; 245(1-2):161-7. PubMed ID: 16631206
    [Abstract] [Full Text] [Related]

  • 13. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.
    Porcel J, Montalban X.
    J Neurol Sci; 2006 Jun 15; 245(1-2):177-81. PubMed ID: 16674980
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.
    Bagnato F, Ohayon JM, Ehrmantraut M, Chiu AW, Riva M, Ikonomidou VN.
    Expert Rev Neurother; 2006 Apr 15; 6(4):599-612. PubMed ID: 16623658
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A.
    J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Neuropsychological evaluation in a case of multiple sclerosis].
    Sanz de la Torre JC, Pérez-Ríos M.
    Rev Neurol; 2009 Jul 15; 30(12):1161-5. PubMed ID: 10935244
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.